Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KETOPROTACTION: Ketoanalogue Supplementation for Muscle Protection in CKD
NCT07374042Phase 3Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jan 2026
- Primary completion
- Jan 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Ketosteril in chronic kidney disease (CKD), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Started Jan 2026; status: recruiting.
02
Drugs
Ketosteril
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07374042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07374042.